SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare
2 references·9 citing·30 second hop
Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare (2012)Promoting drug discovery by collaborative…How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)How to improve R&D productivi…Open access chemical and clinical probes to support drug discovery (2009)Open access chemical and clin…When more isn’t merrier: pharmaceutical alliance networks and breakthrough innovation (2019)When more isn’t merrier: phar…Opportunities and Challenges for Drug Development: Public–Private Partnerships, Adaptive Designs and Big Data (2016)Opportunities and Challenges …Leveraging Industry‐Academia Collaborations in Adaptive Biomedical Innovation (2016)Leveraging Industry‐Academia …Collaboration for success: the value of strategic col-laborations for precision medicine and biomarker discovery (2016)Collaboration for success: th…Collaborative practices for medicinal chemistry research across the big pharma and not-for-profit interface (2014)Collaborative practices for m…Collaborative Innovation in Pharmaceutical Industry: Approaches and Requirements (2014)Collaborative Innovation in P…New Financing Methods in the Biopharma Industry: A Case Study of Royalty Pharma, Inc. (2013)New Financing Methods in the …Fulfilling the Promise of Technology Transfer (2013)Fulfilling the Promise of Tec…“Collaborative Innovation”—Regaining the Edge in Drug Discovery (2013)“Collaborative Innovation”—Re…Grants4Targets – an innovative approach to translate ideas from basic research into novel drugs (2010)An index to quantify an individual's scientific research output (2005)Are Patents Impeding Medical Care and Innovation? (2010)Role and reality: technology transfer at Canadian universities (2010)US academic drug discovery (2011)Internet-based tools for communication and collaboration in chemistry (2008)The impact of mergers on pharmaceutical R&D (2011)Collaborative innovation during the drug discovery and development process (2025)Open Innovation: The New Imperative for Creating and Profiting from Technology (2003)Can the pharmaceutical industry reduce attrition rates? (2004)Lessons from 60 years of pharmaceutical innovation (2009)A Proof for the Queuing Formula: L = λ W (1961)The Goal: A Process of Ongoing Improvement (1984)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018 (2020)Diagnosing the decline in pharmaceutical R&D efficiency (2012)Industry–academia collaborations for biomarkers (2015)Drug discovery in pharmaceutical industry: productivity challenges and trends (2012)Towards an open R&D system: Internal R&D investment, external knowledge acquisition and innovative performance (2012)Big data for big pharma (2018)Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework (2014)Segmental differences in pharmaceutical industry and its impact on supply chain performance (2019)Typological analysis of public-private partnerships in the veterinary domain (2019)Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research (2021)Absorptive Capacity: A New Perspective on Learning and Innovation (1990)A critical look at technological innovation typology and innovativeness terminology: a literature review (2002)The Performance of Incumbent Firms in the Face of Radical Technological Innovation (2003)Collaborative Strategic Foresight and New Product Development in Chinese Pharmaceutical Firms (2020)The price of innovation: new estimates of drug development costs (2003)Spending on new drug development1 (2009)
this work references cited by second hop

References

  • 2010How to improve R&D productivity: the pharmaceutical industry's grand challenge3,686 cited
  • 2009Open access chemical and clinical probes to support drug discovery130 cited

Cited by

  • 2016Opportunities and Challenges for Drug Development: Public–Private Partnerships, Adaptive Designs and Big Data103 cited
  • 2019When more isn’t merrier: pharmaceutical alliance networks and breakthrough innovation23 cited
  • 2013New Financing Methods in the Biopharma Industry: A Case Study of Royalty Pharma, Inc.14 cited
  • 2016Leveraging Industry‐Academia Collaborations in Adaptive Biomedical Innovation11 cited
  • 2014Collaborative practices for medicinal chemistry research across the big pharma and not-for-profit interface9 cited
  • 2013“Collaborative Innovation”—Regaining the Edge in Drug Discovery9 cited
  • 2016Collaboration for success: the value of strategic col-laborations for precision medicine and biomarker discovery5 cited
  • 2014Collaborative Innovation in Pharmaceutical Industry: Approaches and Requirements5 cited
  • 2013Fulfilling the Promise of Technology Transfer4 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work